Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type
about
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update.Outcome of intracerebral hemorrhage associated with different oral anticoagulants.Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.CDKN2B methylation is associated with carotid artery calcification in ischemic stroke patients.Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis.Medical management of intracerebral haemorrhage.Reversal of direct oral anticoagulants.Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal.Decision Algorithms for Direct Oral Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: A Practical Guide for Neurologists.Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.Resumption of Anticoagulation After Intracranial Hemorrhage.Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants.A practical guide on how to handle patients with bleeding events while on oral antithrombotic treatment.Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin.Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis.Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model.Serum Magnesium Levels and Outcomes in Patients With Acute Spontaneous Intracerebral Hemorrhage.
P2860
Q30238502-E2745BE2-645F-4CDF-B544-8780CBA18D32Q33617298-F5900D91-2E1B-401C-85D4-49E7D698935DQ34555332-285FBF97-8909-4720-BCB7-C1BC04376605Q37466544-44C7009C-9130-4B4C-915C-F43BFD07921FQ38950746-F0037387-A7D4-4BBC-A95A-DD1917B56937Q39010418-8F1F93CB-5813-4141-8C5A-A8602A2AAF5EQ39170777-FBCF16B5-F471-4C34-B4FF-D0E87671330AQ39452481-2C45155F-D1BE-4887-A7C3-FFF8093F53F5Q47686273-8A5B7174-6459-41EF-9F21-69E8D1CACFECQ47838584-95EA0426-FF43-4ED6-B955-AF64ADA4F1C6Q47891553-F1418A40-E5FE-42AC-9D07-9683330E072EQ53668632-C75CE997-3852-4C6C-A8EC-4E2702D5B4E6Q55192415-7448DDB0-6C45-4B64-80C0-7ED2035EBCD7Q55342043-CF82FE09-55DD-4F6C-BD3E-CEF8962B1D6DQ55354315-804D8DA2-84FD-4D13-866F-AEEBF681C2E1Q55361115-3983F324-D73B-4ED6-8E66-0331C84C1A28Q55446813-B28490BB-F431-4AED-ACB3-F10A40386026
P2860
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Volume and functional outcome ...... ing to oral anticoagulant type
@ast
Volume and functional outcome ...... ing to oral anticoagulant type
@en
type
label
Volume and functional outcome ...... ing to oral anticoagulant type
@ast
Volume and functional outcome ...... ing to oral anticoagulant type
@en
prefLabel
Volume and functional outcome ...... ing to oral anticoagulant type
@ast
Volume and functional outcome ...... ing to oral anticoagulant type
@en
P2093
P2860
P50
P1433
P1476
Volume and functional outcome ...... ing to oral anticoagulant type
@en
P2093
Andreas Charidimou
CROMIS-2 collaborators
Clare Shakeshaft
David J Werring
Duncan Wilson
Gareth Ambler
Hannah Cohen
Hans Rolf Jäger
Mark White
Martin M Brown
P2860
P304
P356
10.1212/WNL.0000000000002310
P407
P577
2015-12-30T00:00:00Z